Popular Articles

Royal College of Physicians President Responds To The Public Accounts Committe Report Into Health Services For Harmful Drinkers, UK
Responding to the publication of the Public Accounts Committee"s report Reducing Alcohol Harm: Health services in England for alcohol misuse, Professor Ian Gilmore, President of the Royal College of Physicians said [of the report]:
generic viagra online KISS THE BABY - WD
MuGard Data From UK Study Shows Prevention Of Oral Mucositis In Head And Neck Cancer Patients
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced that its European partner, SpePharm, is collecting data from a post approval study of MuGard in head and neck cancer patients undergoing radiation treatment in the UK showing prevention of oral mucositis. In a multi-center study expected to enroll a total of 280 patients, patients are provided with seven weeks of MuGard therapy, and begin using MuGard one week prior to radiation treatment and then throughout the subsequent six weeks of planned therapy. The first 140 patients being treated in this assessment study have been enrolled and treated, and as of the time of the update, none of these patients have experienced any oral mucositis.
News of the day
Glimpsing The Birth Of Our Earliest Reproductive Cells
It has long been a mystery how the developing embryo designates those rare, precious cells destined to produce sperm and eggs -- enabling us to have offspring - since these primordial germ cells" existence is fleeting and hard to spot with the tools of biology. Now, using mouse embryonic stem cells, researchers in the Stem Cell Program at Children"s Hospital Boston have managed to recapitulate the creation of primordial germ cells (PGCs) in the lab, capturing the stem cells" gene activity as they differentiated to form PGCs. The findings, published in the July 5 issue of Nature, also offer a unique window on cancer.
Cardiovascular

Pneumonic Plague Kills Third Human In Chinese Town

Authorities in China confirmed that a third man has died of pneumonic plague in Ziketan, Qinghai Province, China. The town has been sealed off. The 64-year-old man lived near the other two men who died, officials said. Checkpoints have been set up around Ziketan, a town of 10,000 people, while medics disinfect the area. Teams of workers have been sent in to exterminate rats and insects. Pneumonic plague is caused by Yersina pestis, a bacterial agent that infects the lungs. It is a disease of rodents and their fleas and humans. It can spread from animals to people and from person-to-person. Initial symptoms of pneumonic plague are fever, headache, weakness and a cough which produces bloody or watery sputum. Within two to four days it can cause septic shock. Without early treatment the disease is fatal. It is caused by the same bacterium as the one that caused the Black Death which killed about 25 million people in Europe during the Middle Ages. Human-to-human infection occurs through respiratory droplets. To become infected a human needs to have face-to-face contact with a sick person. If treated early the following antibiotics are effective - streptomycin, tetracycline, and chloramphenicol. Although there is no vaccine, antibiotic treatment for seven days can protect people who have had face-to-face contact with infected people. In the USA the Centers for Disease Control and Prevention (CDC) classify Yersina pestis as a Category A (high priority) bioterrorism agent. The World Health Organization (WHO) has praised Chinese authorities for their swift response and for getting the situation under control. According to the British Broadcasting Corporation (BBC) Chinese authorities are being open about this outbreak. Local media report that so far approximately ten people have become infected. Authorities are urging anyone showing symptoms who has been to the town since the middle of July to seek medical attention immediately. Written by Christian Nordqvist Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):